Concerning CD39, it was also found that CD8+ TILs from lung cancer and CRC were not only specific for tumor antigens but also could recognize a broad range of epitopes unrelated to cancer, and that CD39 was critical to distinguish tumor-specific CD8+ TILs from bystander CD8+ T cells (150). This evidence concerns the gene ENTPD1 and lung carcinoma.